Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical Performance of the Roche SARS-CoV-2 Serologic Assay
Mei San Tang, Karl Hock, Nicole M Logsdon, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 8, pp. 1107-1109
Open Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Neutralizing Antibodies Correlate with Protection from SARS-CoV-2 in Humans during a Fishery Vessel Outbreak with a High Attack Rate
Amin Addetia, Katharine H. D. Crawford, Adam S. Dingens, et al.
Journal of Clinical Microbiology (2020) Vol. 58, Iss. 11
Open Access | Times Cited: 575
Potential Antigenic Cross-reactivity Between Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Dengue Viruses
Yaniv Lustig, Shlomit Keler, Rachel Kolodny, et al.
Clinical Infectious Diseases (2020) Vol. 73, Iss. 7, pp. e2444-e2449
Open Access | Times Cited: 167
Side-by-Side Comparison of Three Fully Automated SARS-CoV-2 Antibody Assays with a Focus on Specificity
Thomas Perkmann, Nicole Perkmann‐Nagele, Marie‐Kathrin Breyer, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 11, pp. 1405-1413
Open Access | Times Cited: 132
Association between SARS-CoV-2 Neutralizing Antibodies and Commercial Serological Assays
Mei San Tang, James Brett Case, Caroline E Franks, et al.
Clinical Chemistry (2020) Vol. 66, Iss. 12, pp. 1538-1547
Open Access | Times Cited: 127
Quantification of antibody avidities and accurate detection of SARS-CoV-2 antibodies in serum and saliva on plasmonic substrates
Tiancheng Liu, Jessica Hsiung, Su Zhao, et al.
Nature Biomedical Engineering (2020) Vol. 4, Iss. 12, pp. 1188-1196
Open Access | Times Cited: 95
Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain
Chao Wu, Abraham J. Qavi, Asmaa Hachim, et al.
iScience (2021) Vol. 24, Iss. 6, pp. 102681-102681
Open Access | Times Cited: 92
Comparison of the diagnostic sensitivity of SARS-CoV-2 nucleoprotein and glycoprotein-based antibody tests
Carolin Schnurra, Nina Reiners, Ronald Biemann, et al.
Journal of Clinical Virology (2020) Vol. 129, pp. 104544-104544
Open Access | Times Cited: 80
Commercial Serology Assays Predict Neutralization Activity against SARS-CoV-2
Raymond T. Suhandynata, Melissa Hoffman, Deli Huang, et al.
Clinical Chemistry (2020) Vol. 67, Iss. 2, pp. 404-414
Open Access | Times Cited: 67
Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with high attack rate
Amin Addetia, Katharine H. D. Crawford, Adam S. Dingens, et al.
medRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 59
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody
Mary‐Anne Trabaud, Vinca Icard, Marie-Paule Milon, et al.
Journal of Clinical Virology (2020) Vol. 132, pp. 104613-104613
Open Access | Times Cited: 58
Evaluation of three fully-automated SARS-CoV-2 antibody assays
Sebastian Hörber, Jelena Soldo, Lasse Relker, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2020) Vol. 58, Iss. 12, pp. 2113-2120
Open Access | Times Cited: 45
Comparison of the Clinical Performances of the Abbott Alinity IgG, Abbott Architect IgM, and Roche Elecsys Total SARS-CoV-2 Antibody Assays
Kellisha Harley, Ian L. Gunsolus
Journal of Clinical Microbiology (2020) Vol. 59, Iss. 1
Open Access | Times Cited: 44
Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
Verena Haselmann, Maximilian Kittel, Catharina Gerhards, et al.
Clinica Chimica Acta (2020) Vol. 510, pp. 73-78
Open Access | Times Cited: 43
Head-to-Head Comparison of Two SARS-CoV-2 Serology Assays
Anna E. Merrill, J. Brooks Jackson, Alexandra Ehlers, et al.
The Journal of Applied Laboratory Medicine (2020) Vol. 5, Iss. 6, pp. 1351-1357
Open Access | Times Cited: 41
Antibodies against severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2) in individuals with and without COVID-19 vaccination: A method comparison of two different commercially available serological assays from the same manufacturer
Thomas Mueller
Clinica Chimica Acta (2021) Vol. 518, pp. 9-16
Open Access | Times Cited: 36
Analytical and Clinical Evaluation of the Automated Elecsys Anti–SARS-CoV-2 Antibody Assay on the Roche cobas e602 Analyzer
Clarence W. Chan, Kyle Parker, Vera Tešić, et al.
American Journal of Clinical Pathology (2020) Vol. 154, Iss. 5, pp. 620-626
Open Access | Times Cited: 33
Multi-Platform Comparison of SARS-CoV-2 Serology Assays for the Detection of COVID-19
Raymond T. Suhandynata, Melissa Hoffman, Michael J. Kelner, et al.
The Journal of Applied Laboratory Medicine (2020) Vol. 5, Iss. 6, pp. 1324-1336
Open Access | Times Cited: 32
Evaluation of an Electrochemiluminescent SARS-CoV-2 Antibody Assay
Chin-Shern Lau, S.P. Hoo, S F Yew, et al.
The Journal of Applied Laboratory Medicine (2020) Vol. 5, Iss. 6, pp. 1313-1323
Open Access | Times Cited: 29
Characteristics of Three Different Chemiluminescence Assays for Testing for SARS-CoV-2 Antibodies
Myriam Weber, Martin Risch, Sarah Thiel, et al.
Disease Markers (2021) Vol. 2021, pp. 1-13
Open Access | Times Cited: 20
Clinical Validation and Performance Evaluation of the Automated Vitros Total Anti–SARS-CoV-2 Antibodies Assay for Screening of Serostatus in COVID-19
Emily Garnett, Joanna Jung, Estella Tam, et al.
American Journal of Clinical Pathology (2020) Vol. 154, Iss. 6, pp. 742-747
Open Access | Times Cited: 20
SARS-CoV-2 infection serology validation of different methods: Usefulness of IgA in the early phase of infection
Massimo Pieri, Marco Ciotti, Nicoletta Carlozzi, et al.
Clinica Chimica Acta (2020) Vol. 511, pp. 28-32
Open Access | Times Cited: 20
Clinical performance of three fully automated anti‐SARS‐CoV‐2 immunoassays targeting the nucleocapsid or spike proteins
Julien Favresse, Julie Cadrobbi, Christine Eucher, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 4, pp. 2262-2269
Open Access | Times Cited: 20
Response of anti-SARS-CoV-2 total antibodies to nucleocapsid antigen in COVID-19 patients: a longitudinal study
Julien Favresse, Christine Eucher, Marc Elsen, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2020) Vol. 58, Iss. 10, pp. e193-e196
Open Access | Times Cited: 19
Temporal Course of SARS-CoV-2 Antibody Positivity in Patients with COVID-19 following the First Clinical Presentation
Martin Risch, Myriam Weber, Sarah Thiel, et al.
BioMed Research International (2020) Vol. 2020, pp. 1-11
Open Access | Times Cited: 18
Association between SARS-CoV-2 neutralizing antibodies and commercial serological assays
Mei San Tang, James Brett Case, Caroline E Franks, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2020)
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top